Enzo Biochem Tells Annual Meeting Growth in Life Sciences is Driving Revenue Gains in Fiscal 2009

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) said today that it anticipates increased revenues in fiscal 2009 which ends in July, stemming largely from the Company’s expanded activities and interests in the life sciences field.